Cargando…
Investigating Antiarthritic Potential of Nanostructured Clove Oil (Syzygium aromaticum) in FCA-Induced Arthritic Rats: Pharmaceutical Action and Delivery Strategies
The combined application of clove oil in a lipid nanocarrier opens a promising avenue for bone and joints therapy. In this study, we successfully developed a tunable controlled-release lipid platform for the efficient delivery of clove oil (CO) for the treatment of rheumatoid arthritis (RA). The ult...
Autores principales: | Shakeel, Faiyaz, Alam, Prawez, Ali, Abuzer, Alqarni, Mohammed H., Alshetaili, Abdullah, Ghoneim, Mohammed M., Alshehri, Sultan, Ali, Amena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658777/ https://www.ncbi.nlm.nih.gov/pubmed/34885909 http://dx.doi.org/10.3390/molecules26237327 |
Ejemplares similares
-
Bioactivity of the Ethanol Extract of Clove (Syzygium aromaticum) as Antitoxin
por: Afrendi, Erwin, et al.
Publicado: (2023) -
Determination of Thymol in Commercial Formulation, Essential Oils, Traditional, and Ultrasound-Based Extracts of Thymus vulgaris and Origanum vulgare Using a Greener HPTLC Approach
por: Foudah, Ahmed I., et al.
Publicado: (2022) -
The clove (Syzygium aromaticum) genome provides insights into the eugenol biosynthesis pathway
por: Ouadi, Sonia, et al.
Publicado: (2022) -
Simultaneous Determination of Caffeine and Paracetamol in Commercial Formulations Using Greener Normal-Phase and Reversed-Phase HPTLC Methods: A Contrast of Validation Parameters
por: Alam, Prawez, et al.
Publicado: (2022) -
Eugenol-rich Fraction of Syzygium aromaticum (Clove) Reverses Biochemical and Histopathological Changes in Liver Cirrhosis and Inhibits Hepatic Cell Proliferation
por: Ali, Shakir, et al.
Publicado: (2014)